|
 In a landmark declaration aligning with International Women's Day, Supriya Lifescience Ltd., a distinguished global manufacturer of active pharmaceutical ingredients (APIs), has underscored the indispensable contribution of women to India's ambitious pursuit of a USD 5 trillion economy by 2027.
Supriya Lifescience has a well-established presence in API manufacturing with focus in products of various therapeutic segments like – anti-histamine, anti-allergics, vitamins, anaesthetics, anti- asthmatics etc.
Director of Supriya Lifescience, Dr. Saloni Wagh, delivered a resounding tribute to women, portraying them as dynamic agents of change within India's economic landscape. Dr. Wagh emphasized that women are not passive observers but active catalysts across diverse sectors, from pharmaceutical and healthcare to technology, driving growth and fostering innovation.
"Today, as we commemorate International Women's Day, it's imperative to recognize the pivotal role of women in propelling our nation towards economic prosperity," remarked Dr. Wagh.
"Initiatives such as the Mudra Yojana and increased female enrollment in higher education serves as testament to our unwavering commitment to female empowerment, vital for achieving our USD 5 trillion ambition," Dr. Wagh added.
Supriya Lifescience's dedication to gender equality and inclusive growth is deeply ingrained within its ethos, as highlighted by Dr. Wagh. Founded by Dr Satish Wagh, a visionary first-generation entrepreneur, the company's core values revolve around ethical practices and environmental health and safety standards, further reinforcing its commitment to societal progress.
Dr. Wagh's statement not only reflects the ethos of Supriya Lifescience but also symbolizes a broader acknowledgment of women's indispensable role in driving economic advancement. As the company continues to lead in API manufacturing, it sets a powerful precedent for the pharmaceutical industry and beyond, championing the empowerment and recognition of women as fundamental pillars of economic success.
Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of APIs. Its state-of-the-art facility is certified by US FDA, EDQM, EUGMP, NMPA & Health Canada. The facility is located at Khed, District Ratnagiri and headquartered in Mumbai, India.
|